| Mark C Pettus, MD | |
|
3578 Toomer Kiln Cir, Mt Pleasant, SC 29466-9260 | |
| (843) 884-4810 | |
| Not Available |
| Full Name | Mark C Pettus |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 3578 Toomer Kiln Cir, Mt Pleasant, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528055209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 28214 (South Carolina) | Primary |
| Entity Name | Berkshire Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295765261 PECOS PAC ID: 1355232711 Enrollment ID: O20040324000088 |
News Archive
Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The increasing prevalence of both gout and chronic kidney disease has led to a growing interest in the association between hyperuricemia (an abnormally high level of uric acid in the blood) and kidney disease.
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.
› Verified 6 days ago
| Entity Name | Berkshire Faculty Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548212939 PECOS PAC ID: 8224068424 Enrollment ID: O20050817001122 |
News Archive
Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The increasing prevalence of both gout and chronic kidney disease has led to a growing interest in the association between hyperuricemia (an abnormally high level of uric acid in the blood) and kidney disease.
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Pettus, MD 138 Patricia Ave, Dalton, MA 01226-2045 Ph: (413) 684-2305 | Mark C Pettus, MD 3578 Toomer Kiln Cir, Mt Pleasant, SC 29466-9260 Ph: (843) 884-4810 |
News Archive
Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
The increasing prevalence of both gout and chronic kidney disease has led to a growing interest in the association between hyperuricemia (an abnormally high level of uric acid in the blood) and kidney disease.
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.
› Verified 6 days ago
Dr. Michael Mikola, MD Nephrology Medicare: Medicare Enrolled Practice Location: 180 Wingo Way, Stse 306, Mt Pleasant, SC 29464 Phone: 843-884-1777 Fax: 843-884-0710 | |
Jonathan Edward Parrack, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1300 Hospital Dr Ste 300, Mt Pleasant, SC 29464 Phone: 843-884-5200 | |
Jenny Mccallister Riley, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3510 N Highway 17 Ste 225, Mt Pleasant, SC 29466 Phone: 843-881-5844 Fax: 843-789-1791 | |
John W Mcdonald, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1208 Two Island Ct, Mt Pleasant, SC 29466 Phone: 843-884-6653 | |
Dr. Bryan H Frain, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 897 Von Kolnitz Road, Suite 101, Mt Pleasant, SC 29464 Phone: 843-534-1770 Fax: 877-453-3943 | |
Dr. Robert Scott Thompson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 498 Wando Park Blvd Ste 500, Mt Pleasant, SC 29464 Phone: 843-216-8139 Fax: 866-834-5680 | |
Dr. David Michael Ingraham, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1300 Hospital Dr, Suite 300, Mt Pleasant, SC 29464 Phone: 843-884-5200 Fax: 843-884-6417 |